You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Nigeria

Jul 2011

Price: US$2,400

About this Report

About this Report

Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Nigeria with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Nigeria, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Nigeria for free:

The Consumer Health in Nigeria market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Nigeria?
  • What are the major brands in Nigeria?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

EXECUTIVE SUMMARY

Economic recovery helps growth, though it is offset by fall in production

With an improvement in GDP growth in 2010 compared to 2009, the overall consumer health market performed fairly robustly in 2010 in value terms. However, during the year, the National Agency for Food and Drug Administration and Control (NAFDAC) required that all companies overhaul and upgrade their equipment and facilities, leading to a fall in local production that affected the availability of locally produced drugs; this requirement wound up slowing growth more than would have otherwise been expected during 2010. Full production for most manufacturers was supposed to commence in October 2010, so the market is expected to see even stronger growth in 2011.

National drugs regulator introduces new technology against fake drugs

NAFDAC, which regulates the production and importation of consumer drugs in Nigeria, has intensified its campaign against fake drugs, which are widespread in the country. It has insisted that all manufacturers of drug products implement a new anti-counterfeiting technology based on the radio-frequency identification (RFID) system to enable pharmacists to detect counterfeit drugs by use of the Mobile Authentication Services (MAS). Pharmacists would have a reader that can scan drug packs, which by law are required to be tagged. When a package is counterfeit, it would have been improperly tagged and therefore detectable. Although this would increase costs for producers in the short term, it would ultimately have the positive effect of increasing sales of genuine products and therefore contributing to strong growth over the forecast period.

Cadbury and Emzor Pharmaceuticals continue to lead OTC sales

Although the overall leader of the over-the-counter market is Cadbury, this is due entirely to sales of its medicated confectionery brand, Tom-Tom, which is sold widely in most channels. Excluding Cadbury, Emzor Pharmaceuticals continued to lead the rest of the OTC sales (and overall consumer health market) in 2010, due to its stable of popular analgesic brands, which are relatively cheap compared to that of the competition, as well as being well known. Other major players that have continued to perform well are GlaxoSmithKline, which has the popular Panadol brand, Neimeth International Pharmaceuticals and May & Baker Nigeria.

Independent chemists/pharmacies remains major channel for product distribution

Independent chemists/pharmacies remain the major channel for the distribution of consumer healthcare products in Nigeria. Located in all major cities and towns and in many villages across the country, they retail foreign and local products, especially in smaller units. The larger parapharmacies/drugstores have seen increasing share due to an increase in outlets and wider range of brands. Herbal/traditional product manufacturers that operate the direct selling model have benefited from the growing number of agents and distributors for their products across the country. Internet retailing has been introduced in Nigeria, but its contribution to the overall distribution of consumer healthcare products remains insignificant.

Growth expected to rebound over forecast period

The performance of the consumer health market is expected to rebound over the forecast period. Though quite positive, growth in 2010 was slowed by fall in production due to NAFDAC’s required overhauling of production facilities, and should be faster over the first few years of the forecast period in constant value. This will be as a result of positive population growth in the country, government efforts to check the activities of grey market operators, and improved GDP growth.

Table of Contents

Table of Contents

Consumer Health in Nigeria - Industry Overview

EXECUTIVE SUMMARY

Economic recovery helps growth, though it is offset by fall in production

National drugs regulator introduces new technology against fake drugs

Cadbury and Emzor Pharmaceuticals continue to lead OTC sales

Independent chemists/pharmacies remains major channel for product distribution

Growth expected to rebound over forecast period

KEY TRENDS AND DEVELOPMENTS

Battle against fake drugs threat intensifies

Economy is growing but consumer expenditure remains weak

Despite ageing trend, Nigeria’s population remains relatively young

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2005-2010
  • Table 2 Life Expectancy at Birth 2005-2010

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2005-2010
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2005-2010
  • Table 5 Consumer Health Company Shares 2006-2010
  • Table 6 Consumer Health Brand Shares 2007-2010
  • Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
  • Table 8 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 9 Forecast Sales of Consumer Health by Category: Value 2010-2015
  • Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015

APPENDIX

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventative Medicine

Switches

DEFINITIONS

  • Summary 1 Research Sources

Consumer Health in Nigeria - Company Profiles

Evans Medical Plc in Consumer Health (Nigeria)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 4 Evans Medical Plc: Competitive Position 2010

May & Baker Nigeria Plc in Consumer Health (Nigeria)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 7 May & Baker Nigeria Plc: Competitive Position 2010

Neimeth International Pharmaceuticals Plc in Consumer Health (Nigeria)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 10 Neimeth International Pharmaceuticals Plc: Competitive Position 2010

Nigerian-German Chemicals Plc in Consumer Health (Nigeria)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 13 Nigerian-German Chemicals Plc : Competitive Position 2010

Adult Mouth Care in Nigeria - Category Analysis

HEADLINES

TRENDS

  • Current value sales of adult mouth care in Nigeria were up by 9% to reach NGN800 million in 2010. There is growing demand for such products as an increasing number of Nigerians take oral health more seriously and proactively. Although this began with upper-income consumers, middle class consumers are increasingly using mouthwash treatments or gels to cure minor ailments while in the past they would have simply waited for it to pass.

SWITCHES

COMPETITIVE LANDSCAPE

  • Pharma-Deko Plc accounted for 40% of value sales of adult mouth care in 2010, through its ownership of two leading brands – Brett Mouthwash, the leading brand, and Hexedene, the third-ranked brand. The company was also the fastest-growing company in 2010, with a 0.3 percentage point increase in value share.

PROSPECTS

  • Over the forecast period, constant value sales of adult mouth care are expected to remain flat compared with a 2% CAGR decline seen in the review period.

CATEGORY DATA

  • Table 11 Sales of Adult Mouth Care: Value 2005-2010
  • Table 12 Sales of Adult Mouth Care: % Value Growth 2005-2010
  • Table 13 Adult Mouth Care Company Shares 2006-2010
  • Table 14 Adult Mouth Care Brand Shares 2007-2010
  • Table 15 Forecast Sales of Adult Mouth Care: Value 2010-2015
  • Table 16 Forecast Sales of Adult Mouth Care: % Value Growth 2010-2015

Analgesics in Nigeria - Category Analysis

HEADLINES

TRENDS

  • The entire analgesics category is the largest in value terms, and one of the most dynamic in Nigeria’s consumer health industry. Reasons for growth include easy accessibility of the products, the use of many products to treat multiple ailments, and intense advertising for leading brands such as Emzor Paracetamol and Panadol. There was also a gradual shift from herbal remedies to orthodox medicine by a significant proportion of the population due to better education and awareness of the dangers of unregulated traditional practices. There are no major warnings about acetaminophen overdose potential, although newspapers have increasingly highlighted the dangers of addiction to painkillers.

SWITCHES

COMPETITIVE LANDSCAPE

  • The leading player in 2010 in analgesics was Emzor Pharmaceutical Industries, with a 14% value share. The company’s leading position is due to its ownership of the Emzor Pharmaceutical brand in particular, which is supported by effective and innovative marketing strategies. The relatively lower price of its brands compared to that of competitors is also a factor in the company’s leading share. GlaxoSmithKline Nigeria followed closely behind with a 12% value share through its Panadol brand.

PROSPECTS

  • Over the forecast period, constant value sales of analgesics are expected to increase at a CAGR of 1%, largely due to the improving economy following the economic crisis and to the expected decline in the prevalence of fake and substandard drugs in the country. In addition, the federal government’s efforts at improving the National Health Insurance Scheme, as well as the efforts of some state governments to offer free medical care to some very low-income citizens, are expected to increase the accessibility of analgesics to more Nigerians, thereby boosting growth.

CATEGORY DATA

  • Table 17 Sales of Analgesics by Category: Value 2005-2010
  • Table 18 Sales of Analgesics by Category: % Value Growth 2005-2010
  • Table 19 Analgesics Company Shares 2006-2010
  • Table 20 Analgesics Brand Shares 2007-2010
  • Table 21 Forecast Sales of Analgesics by Category: Value 2010-2015
  • Table 22 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015

Cough, Cold and Allergy (Hay Fever) Remedies in Nigeria - Category Analysis

HEADLINES

TRENDS

  • The spread of cold and cough ailments is largely under control amongst adults as a result of improved hygiene and better preventative medical practices. However, the incidence is still very high amongst children and low-income families, where poor hygiene and inadequate ventilation in houses represent major drivers of new infections. And with high rates of self-medication or dependence on pharmacies’ advice in a country where public healthcare is generally poor and private healthcare is expensive, over-the-counter cough, cold and allergy remedies are in high demand. Advertising is generally widespread, so brands are well known and are generally easily available in pharmacies and other outlets.

SWITCHES

COMPETITIVE LANDSCAPE

  • Cadbury led sales in this category in 2010, but this was simply due to its Tom Tom brand, which dominates the very large medicated confectionery category, with over 95% of sales in this category. With volume sales of over 10,000 tonnes and value sales of almost 10 billion, it therefore dwarfs other brands in the category, despite the product not being strictly considered an OTC drug by most consumers who can purchase it in a wide variety of outlets including street kiosks. It is generally used to soothe the throat when there are mild signs of a cold or congestion, or to give good breath (it is quite popular amongst smokers for masking the smell of cigarettes).

PROSPECTS

  • One of the resultant effects of Nigeria’s growing population is the congestion of many urban areas, leading to the easy spread of germs and viruses through cough. Children in densely populated schools and neighbourhoods are mostly at risk, especially since their knowledge of the practice of preventative medical care is limited. This trend is expected to boost the growth of cough, cold and allergy (hay fever) remedies in Nigeria, which is expected to see a constant value CAGR of 2% over the forecast period. Furthermore, health campaigns by government agencies on the need to treat early symptoms of cough and other allergies, as well as the prevalent culture of self-medication are expected to result in the continued growth of value sales. Lastly, the economy’s improvement following the 2009 crisis will support increased value growth as consumers are more able to afford such drugs.

CATEGORY DATA

  • Table 23 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 24 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 25 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares 2006-2010
  • Table 26 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares 2007-2010
  • Table 27 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2010-2015
  • Table 28 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2010-2015

Digestive Remedies in Nigeria - Category Analysis

HEADLINES

TRENDS

  • Following slow growth in 2009 due to the global economic downturn, the category recorded even slower growth in 2010, of 6%, being affected by slower production due to the NAFDAC-required production equipment overhaul, as well as reduced demand. Consumers who had increasingly turned to homemade remedies for certain ailments, such as diarrhoea and indigestion, continued to do so in 2010. The category was particularly affected because of the easy accessibility of traditional and homemade substitutes for common digestive ailments in most communities across the country.

SWITCHES

COMPETITIVE LANDSCAPE

  • Ranbaxy Laboratories led digestive remedies in 2010 with a value share of 11% due to its popular antacid brand, Gestid, which is the leading brand in the country. The brand is heavily advertised and widely distributed, so it has become quite well known as an antacid brand. The company also saw the biggest increase in share amongst leading players due to its strong visibility during the year.

PROSPECTS

  • The category is expected to further decrease in the forecast period at -2% CAGR in constant terms. The category is quite mature, and there continues to be competition from effective local herbal/traditional remedies (which are unbranded and unpackaged). With rising prices, consumers resort to ready-made alternatives with such traditional remedies. In constant value terms, the category is expected to decline by almost 2% (although it will grow at a CAGR of 7% in current value terms).

CATEGORY DATA

  • Table 29 Sales of Digestive Remedies by Category: Value 2005-2010
  • Table 30 Sales of Digestive Remedies by Category: % Value Growth 2005-2010
  • Table 31 Digestive Remedies Company Shares 2006-2010
  • Table 32 Digestive Remedies Brand Shares 2007-2010
  • Table 33 Forecast Sales of Digestive Remedies by Category: Value 2010-2015
  • Table 34 Forecast Sales of Digestive Remedies by Category: % Value Growth 2010-2015

Ear Care in Nigeria - Category Analysis

HEADLINES

TRENDS

  • Ear care in Nigeria grew by 5% in current value terms in 2010 to reach more than NGN300 million. Awareness of over-the-counter products is limited in this category, as it is in eye care. Most sufferers depend on advice from doctors or pharmacists, and are likely to leave a minor condition untreated until it becomes a major concern. Ear care products are mostly purchased by middle- to upper-income consumers who are often more enlightened and would not allow a condition to last too long before obtaining a treatment.

SWITCHES

COMPETITIVE LANDSCAPE

  • In a highly fragmented market, Drugfield Pharmaceuticals Ltd led ear care with a value share of 2% in 2010. Its brand, Betadrone-N, has a good distribution in stores, and is relatively low priced. Other significant players are international players, such as Sanofi-Aventis Nigeria Ltd.

PROSPECTS

  • In Nigeria constant value sales of ear care are expected to see a CAGR of -3% over the forecast period. In current value terms (where inflation in the economy is included), the category should see a value CAGR of 5%, which is only slightly slower than growth in the review period. The positive performance (in current value terms) would be largely driven by increasing product awareness as a result of access to information via the internet, and the availability of cheaper generic offerings. The category is expected to become even more fragmented, with no particular brand assuming clear leadership.

CATEGORY DATA

  • Table 35 Sales of Ear Care: Value 2005-2010
  • Table 36 Sales of Ear Care: % Value Growth 2005-2010
  • Table 37 Ear Care Company Shares 2006-2010
  • Table 38 Ear Care Brand Shares 2007-2010
  • Table 39 Forecast Sales of Ear Care: Value 2010-2015
  • Table 40 Forecast Sales of Ear Care: % Value Growth 2010-2015

Emergency Contraception in Nigeria - Category Analysis

HEADLINES

TRENDS

  • The emergency contraception category grew by 6% in current value terms to reach NGN200 million in 2010. There is continued reduction in the stigma associated with the use of the product as the country becomes more urbanised. Educated young adults are more and more starting to view it as a safer alternative to abortion.

COMPETITIVE LANDSCAPE

  • Society for Family Health led sales in this category in 2010 with a value share of 28%. Its Postinor and Postinor-2 brands held the leading positions. Society for Family Health is a social marketing organisation (that is, it uses private means to carry out public health objectives) and has exclusive distribution rights from the global company Richter Gedeon Nyrt to distribute these products in Nigeria. The company has a wide and efficient distribution network, and in line with its aims to ensure reproductive health in the country, has made the product widely available in chemists/pharmacies and at Patent Medicine Seller outlets. The brands now have a national distribution, with 700,000 units of Postinor-2 sold in 2005.

PROSPECTS

  • Emergency contraception in Nigeria is expected to record a constant value CAGR of -3% over the forecast period compared to -4% in the historic period.

CATEGORY DATA

  • Table 41 Sales of Emergency Contraception: Value 2005-2010
  • Table 42 Sales of Emergency Contraception: % Value Growth 2005-2010
  • Table 43 Emergency Contraception Company Shares 2006-2010
  • Table 44 Emergency Contraception Brand Shares 2007-2010
  • Table 45 Forecast Sales of Emergency Contraception: Value 2010-2015
  • Table 46 Forecast Sales of Emergency Contraception: % Value Growth 2010-2015

Eye Care in Nigeria - Category Analysis

HEADLINES

TRENDS

  • In 2010, current value sales of eye care increased by 5% to reach approximately NGN900 million. General consumer awareness of the various types of eye care products remains low in the country, with a low level of advertising of such products. But increased eye problems due to smoke pollution, which is a major health issue in Nigeria, and better incomes for a growing middle class have contributed to the positive growth seen in 2010. The ageing of the population is also contributing to growth, with older persons being amongst the most important consumers of such products.

SWITCHES

COMPETITIVE LANDSCAPE

  • Novartis Pharma Services led the category in 2010 with a value share of 14%. This is due to its strong marketing of two major brands in particular – Viscotears (the second ranked brand) and Spersallerg Eye Drops.

PROSPECTS

  • Constant value sales of eye care in Nigeria are expected to decrease at a CAGR of -3% over the forecast period. This is a slight improvement from the -4% constant value CAGR seen over the review period. The negative constant value growth is largely due to inflation, however. The key reasons for this growth include population growth, increasing levels of literacy and the slow but progressive awareness of eye care products amongst consumers. Furthermore, the growing presence of registered generics is expected to make products that were hitherto considered expensive by the average consumer more affordable to a wider proportion of the population.

CATEGORY DATA

  • Table 47 Sales of Eye Care by Category: Value 2005-2010
  • Table 48 Sales of Eye Care by Category: % Value Growth 2005-2010
  • Table 49 Standard Eye Care by Type: % Value Breakdown 2007-2010
  • Table 50 Eye Care Company Shares 2006-2010
  • Table 51 Eye Care Brand Shares 2007-2010
  • Table 52 Forecast Sales of Eye Care by Category: Value 2010-2015
  • Table 53 Forecast Sales of Eye Care by Category: % Value Growth 2010-2015

Herbal/Traditional Products in Nigeria - Category Analysis

HEADLINES

TRENDS

  • In 2010, this category continued to see good growth, benefiting from the trend towards the use of natural herbal/traditional products. This trend, which was driven by the direct selling of dietary supplements by Tianshi Health Products Co Nigeria and Forever Living Products, has spread to boost categories and companies.

COMPETITIVE LANDSCAPE

  • The leading player in herbal/traditional products in 2010 was Plethico Pharmaceuticals with a 25% value share in 2010. This is due to the popularity of the company’s Travisil range of cough, cold and allergy (hay fever) remedies. For dietary supplements, Forever Living Products, Otsuka Pharmaceutical and Tianshi Health Products remained the leading players with a wide range of products and network of distributors across the country. Edmark is gaining popularity in the country, with its retailing strategy being to use a combination of direct sales and in-store retailing.

PROSPECTS

  • The trend towards herbal/traditional products is expected to continue over the forecast period as consumers are increasingly concerned about the side effects of standard drugs and have better incomes enabling them to choose such higher priced brands.

CATEGORY DATA

  • Table 54 Sales of Herbal/Traditional Products: Value 2005-2010
  • Table 55 Sales of Herbal/Traditional Products: % Value Growth 2005-2010
  • Table 56 Herbal/Traditional Products Company Shares 2006-2010
  • Table 57 Herbal/Traditional Products Brand Shares 2007-2010
  • Table 58 Forecast Sales of Herbal/Traditional Products: Value 2010-2015
  • Table 59 Forecast Sales of Herbal/Traditional Products: % Value Growth 2010-2015

Medicated Skin Care in Nigeria - Category Analysis

HEADLINES

TRENDS

  • Although the economy improved in 2010 compared to 2009, this was largely due to oil price increases and consumer spending remained somewhat depressed. Nevertheless, given incomes and expenditures were growing over the review period, medicated skin care continued to grow at a current value CAGR of 8% over the review period. The increase particularly of the young population (under the age of 20) has been an important boost, with products such as medicated shampoos and acne treatments growing by 10% and 4%, respectively, over 2010. The growth also of families with young children, whose disposable income has increased, has also been an important contributor to the growth of topical germicidals and nappy (diaper) rash treatments.

SWITCHES

COMPETITIVE LANDSCAPE

  • The leading company in the category in 2010 was Neimeth International Pharmaceuticals, with a 13% value share. This company’s TCP antiseptic range is quite popular, showed good growth over the review period and remains the clear leader in topical germicidals/antiseptics. The company’s manufacturing of Neo Medrol, a leading acne treatment with wide penetration, on behalf of Pfizer Global Pharmaceuticals also supports its leading position.

PROSPECTS

  • Medicated skin care is expected to see a decline in constant value CAGR over the forecast period of about 1% which is still an improvement compared to the review period growth. Easy access to information via the internet is expected to boost awareness for niche products such as vaginal antifungals and hair loss treatments, especially amongst the educated middle-class population segments. This will be the key driver of growth, as opposed to advertising and other promotional strategies.

CATEGORY DATA

  • Table 60 Sales of Medicated Skin Care by Category: Value 2005-2010
  • Table 61 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
  • Table 62 Medicated Skin Care Company Shares by Value 2006-2010
  • Table 63 Medicated Skin Care Brand Shares 2007-2010
  • Table 64 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
  • Table 65 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015

Sports Nutrition in Nigeria - Category Analysis

HEADLINES

TRENDS

  • The category has benefited from trends towards increased exercising amongst young persons in particular. And with an improved economy in 2010 compared to the previous year, the category saw a growth rate of 11% in current value terms. This is slower than the review period average, due to the fact that the category was only launched in 2005 and saw very fast growth in the years immediately after, with growth rates now stabilising.

COMPETITIVE LANDSCAPE

  • Vitabiotics Nigeria held the dominant share in the category in 2010, with a share of 83%, due to the Wellman Sport brand that it markets. The brand is prominently promoted in chemists/pharmacies and parapharmacies/drugstores, and with a strong brand name has become the product of choice for sports active people. The rest of the category is fragmented with products imported from Asia making up the bulk.

PROSPECTS

  • With increased health awareness and a fitness trend amongst the growing young population, there is strong potential for growth in sports nutrition products, particularly with an improving economy. Although in constant value terms, the category will remain flat over the forecast period, this is because of inflation in the general economy. In current value terms the category is expected to see a CAGR of 9% over the forecast period. This is weaker than that of the review period, only because the category was only launched in 2005 and has shown incredible growth since.

CATEGORY DATA

  • Table 66 Sales of Sports Nutrition: Value 2005-2010
  • Table 67 Sales of Sports Nutrition: % Value Growth 2005-2010
  • Table 68 Sports Nutrition By Format: % Value Breakdown 2007-2010
  • Table 69 Sports Nutrition Company Shares 2006-2010
  • Table 70 Sports Nutrition Brand Shares 2007-2010
  • Table 71 Forecast Sales of Sports Nutrition: Value 2010-2015
  • Table 72 Forecast Sales of Sports Nutrition: % Value Growth 2010-2015

Vitamins and Dietary Supplements in Nigeria - Category Analysis

HEADLINES

TRENDS

  • 2010’s 10% growth was slightly stronger than the review period CAGR. This good performance was due to the growing popularity of dietary supplements and multivitamins, as well as improved income following the economic crisis of 2009. Unlike OTC drugs, which had slower growth relative to 2009 due to production slowdown, vitamins and dietary supplements was able to continue providing a good supply to the market, with many imported products continuing to thrive.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • The leading player in 2010 was Emzor Pharmaceutical Industries led with a value share of 7%. The company has a wide range of adult and child-specific vitamins and multivitamins and successful marketing activities. Its products are generally well advertised in local chemists, with in-store posters and flyers. Thus, the majority of chemists across the country have very visible Emzor branding, thereby endearing the company’s brand in the psyche of consumers, leading to its increased popularity across the country. In addition, in terms of price its positioning makes its products relatively more affordable than those of its major competitors, giving it a huge advantage in volume sales over other companies, which also translates into strong value sales.

PROSPECTS

  • Constant value sales of vitamins and dietary supplements are expected to increase at a constant value CAGR of 2% over the forecast period, which is stronger than the comparative growth in the review period. Better incomes and increased health concerns will continue to drive growth. Nigeria has a very young population, 42% of which are under the age of 15. And with the increase in a fast food culture, there is potential for the increased demand for vitamins and dietary supplements due to unbalanced nutrition.

CATEGORY DATA

  • Table 73 Sales of Vitamins and Dietary Supplements by Category: Value 2005-2010
  • Table 74 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2005-2010
  • Table 75 Dietary Supplements by Positioning 2006-2010
  • Table 76 Vitamins and Dietary Supplements Company Shares 2006-2010
  • Table 77 Vitamins and Dietary Supplements Brand Shares 2007-2010
  • Table 78 Vitamins Brand Shares 2007-2010
  • Table 79 Dietary Supplements Brand Shares 2007-2010
  • Table 80 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2010-2015
  • Table 81 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2010-2015

Weight Management in Nigeria - Category Analysis

HEADLINES

TRENDS

  • With an improved economy and better incomes for the middle class, weight management products showed better growth in 2010 than in 2009 – with consumers feeling more able to spend on what may be considered non-essential products. Increased westernisation and health awareness also continued to drive growth in a country where traditionally bigger weight is not necessarily considered to be a negative thing. Traditionally, women with curvy shapes are considered more attractive in Nigeria. However, growing Western influence on teenagers and young adults is generating a trend towards a slimmer appearance.

COMPETITIVE LANDSCAPE

  • Edmark led sales in 2010 with a 47% value share in a fragmented category. The company’s Edmark MRT Complex, which works as a meal replacement therapy, has helped to drive its growth. This was also underpinned by the vigorous marketing strategies of its distributors and direct selling agents, who specifically target working consumers who represent the main consumer group.

PROSPECTS

  • The category is expected to grow in Nigeria over the forecast period at a constant value CAGR of 2%, which is faster than the review period constant value CAGR of around -0.1%. Growth rates are expected to rise due to Nigeria’s very young population, many of whom are growing in a generation where a slimmed appearance is becoming increasingly attractive and sought after.

CATEGORY DATA

  • Table 82 Sales of Weight Management by Category: Value 2005-2010
  • Table 83 Sales of Weight Management by Category: % Value Growth 2005-2010
  • Table 84 Weight Management Company Shares 2006-2010
  • Table 85 Weight Management Brand Shares 2007-2010
  • Table 86 Forecast Sales of Weight Management by Category: Value 2010-2015
  • Table 87 Forecast Sales of Weight Management by Category: % Value Growth 2010-2015

Wound Care in Nigeria - Category Analysis

HEADLINES

TRENDS

  • Current value sales of wound care in Nigeria grew by 5% in 2010 to reach NGN500 million. The incidence of wounds is high in Nigeria because of frequent disregard for basic safety principles, but higher awareness partly due to increased safety requirements at workplaces is helping to drive growth, with working people transferring the knowledge gained at work to their home environments. Growth is also supported by increased availability in retail channels. Chemists/pharmacies and parapharmacies/drugstores are the main distribution channels, but some large supermarkets such as Game and Shoprite, in cities, have begun to stock wound treatments, widening availability to consumers who no longer have to go specifically to chemists/pharmacies for such products.

COMPETITIVE LANDSCAPE

  • Johnson & Johnson, through its Band-Aid product, led with the category with a 19% value share in 2010. This brand is very well known and widely available in chemists/pharmacies and parapharmacies/drugstores. The company also saw the most value share increase in 2010, up by nearly a one percentage point due to the aforementioned reasons.

PROSPECTS

  • Wound care is forecast to see a constant value CAGR of -3% over the forecast period, which is in line with review period performance. This will be mainly due to the competition from home-made alternatives and black market sales that will impact the category.

CATEGORY DATA

  • Table 88 Sales of Wound Care by Category: Value 2005-2010
  • Table 89 Sales of Wound Care by Category: % Value Growth 2005-2010
  • Table 90 Wound Care Company Shares 2006-2010
  • Table 91 Wound Care Brand Shares 2007-2010
  • Table 92 Forecast Sales of Wound Care by Category: Value 2010-2015
  • Table 93 Forecast Sales of Wound Care by Category: % Value Growth 2010-2015

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Acne Treatments
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Child-Specific Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
    • Vitamins and Dietary Supplements
      • Child-Specific Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
          • Non-Herbal Dietary Supplements
            • Calcium Supplements
            • Co-Enzyme Q10
            • Combination Non-Herbal Dietary Supplements
            • Eye Health Supplements
            • Fish Oils
              • Cod Liver Oil
              • Other Fish Oils
            • Glucosamine
            • Mineral Supplements
            • Omega-3-6-9 (Fish and Non-Fish)
            • Probiotic Supplements
            • Protein Powder
            • Royal Jelly
            • Sam-E
            • Other Non-Herbal Dietary Supplements
          • Tonics and Bottled Nutritive Drinks
          • Vitamins
            • Multivitamins
            • Single Vitamins
              • Vitamin A
              • Vitamin B
              • Vitamin C
              • Vitamin D
              • Vitamin E
              • Other Single Vitamins
        • Weight Management
          • Meal Replacement Slimming
          • OTC Obesity
          • Slimming Teas
          • Weight Loss Supplements
          • Other Slimming Products
        • Herbal/Traditional Products
          • Herbal/Traditional Analgesics
          • Herbal/Traditional Calming and Sleeping Products
          • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
          • Herbal/Traditional Digestive Remedies
          • Herbal/Traditional Medicated Skin Care
          • Herbal/Traditional Medicinal Teas
          • Herbal/Traditional Smoking Cessation Aids
          • Herbal/Traditional Child-Specific Dietary Supplements
          • Herbal/Traditional Dietary Supplements
          • Herbal/Traditional Tonics and Bottled Nutritive Drinks
        • Allergy Care
          • Allergy Eye Care
          • Antihistamines/Allergy Remedies (Systemic)
          • Child-Specific Allergy Remedies
          • Topical Allergy Remedies/Antihistamines
        • Child-Specific Consumer Health
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
          • Child-Specific Cough, Cold and Allergy Remedies
            • Child-Specific Allergy Remedies
            • Child-Specific Cough/Cold Remedies
          • Child-Specific Digestive Remedies
            • Child-Specific Diarrhoeal Remedies
            • Child-Specific Indigestion and Heartburn Remedies
            • Child-Specific Laxatives
            • Child-Specific Motion Sickness Remedies
          • Child-Specific Medicated Skin Care
          • Nappy (Diaper) Rash Treatments
          • Child-Specific Vitamins and Dietary Supplements

      Statistics Included

      Statistics Included

      For each category and subcategory you will receive the following data in Excel format:

      From Passport

      • Market sizes
      • Company shares
      • Brand shares
      • Distribution
      • Analysis by format
      • Analysis by positioning
      • Analysis by type
      • Herbal/traditional vs standard
      • Pricing
      • Smoking population - number of adult smokers
      • Smoking prevalence - % of adult population

      Market size details:

      • Retail volume
      • Retail volume % growth
      • Retail volume per capita
      • Retail value retail selling price % growth
      • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price real (constant 2008) prices % growth
      • Retail value retail selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price % growth
      • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price real (constant 2008) prices % growth
      • Retail value manufacturer selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price nominal (current) prices % growth
      • Retail value retail selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price nominal (current) prices % growth
      • Retail value manufacturer selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY

      Methodology

      Methodology

      Global insight and local knowledge

      With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

      This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

      Industry specialists

      Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

      Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

      The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

      Country and regional analysts

      Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

      In-country research network

      To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

      Research Methodology

      Our research methods

      Each Euromonitor International industry report is based on a core set of research techniques:

      Desk research

      With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

      • National statistics offices governmental and official sources
      • National and international trade press
      • National and international trade associations
      • Industry study groups and other semi-official sources
      • Company financials and annual reports
      • Broker reports
      • Online databases
      • The financial, business and mainstream press

      Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

      Store checks

      Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

      • Place: We track products in all relevant channels, selective and mass, store and non-store
      • Product: What are innovations in products, pack sizes and formats?
      • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
      • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

      Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

      Trade survey

      Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

      Trade surveys allow us to:

      • Fill gaps in available published data per company
      • Generate a consensus view of the size, structure and strategic direction of the category
      • Access year-in-progress data where published sources are out of date
      • Evaluate the experts’ views on current trends and market developments

      In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

      Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

      Company analysis

      At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

      At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

      Forecasts

      Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

      Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

      Data validation

      All data is subjected to an exhaustive review process, at country, regional and global levels.

      The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

      Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

      Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

      Market analysis

      Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

      Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

      my pages

      Want to find out more about this report?

      If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!

      RELATED

      Consumer Lifestyle

      Future Demographic

      Country Report